FDA inspection
Cosmetic Solutions LLC: FDA inspection ending May 10, 2006
FDA inspection 425159 · Voluntary Action Indicated (VAI) · Boca Raton, FL
Key facts
| Inspection ID | 425159 |
|---|---|
| Firm | Cosmetic Solutions LLC |
| FEI number | 3002692859 |
| Address | 6101 Park Of Commerce Blvd |
| City | Boca Raton |
| State | FL |
| ZIP | 33487-8208 |
| Fiscal year | 2006 |
| Inspection end date | May 10, 2006 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Colors and Cosmetics Technology|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs|Drug Quality Assurance|Unapproved and Misbranded Drugs |
| Product type | Drugs, Food/Cosmetics |
At a glance
- 10–99 Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data